Interim

Interim leadership and management solutions

Latest in Interim

How this interim CEO mastered the art of leading through uncertainty
interimAug 20, 2025

How this interim CEO mastered the art of leading through uncertainty

Interim CEO Rachel Stephenson Sheff shares her framework for leading organisations through uncertainty, emphasising accountability and strategic clarity.

132 views
NFLPA appoints interim chief after leadership crisis exposes organizational dysfunction
interimAug 19, 2025

NFLPA appoints interim chief after leadership crisis exposes organizational dysfunction

NFLPA names David White as interim executive director following Lloyd Howell's scandal-hit resignation, demonstrating effective crisis transition management.

106 views
Veteran leader returns as interim chief to rescue struggling nonprofit amid financial crisis
interimAug 18, 2025

Veteran leader returns as interim chief to rescue struggling nonprofit amid financial crisis

Wylde Center appoints veteran interim executive director to navigate financial crisis and organizational turmoil after leadership departure and significant staff exodus.

108 views
Interim market rebounds from brutal 2024 as AI and trade shifts spark opportunities
interimAug 17, 2025

Interim market rebounds from brutal 2024 as AI and trade shifts spark opportunities

Interim management sector shows recovery signs after brutal 2024, with AI projects and trade-driven supply chain changes fueling new job opportunities.

200 views
Woolworths taps interim chief as marketing head departs for M&S
interimAug 6, 2025

Woolworths taps interim chief as marketing head departs for M&S

Woolworths appoints Michael Laxton as interim CMO following Andrew Hicks' departure to M&S, highlighting strategic use of interim leadership during executive transitions.

401 views
Biotech shakeup: Context Therapeutics taps board member for interim CMO role
interimMay 31, 2025

Biotech shakeup: Context Therapeutics taps board member for interim CMO role

Context Therapeutics appoints board member Dr Karen Smith as interim CMO amid 61% stock decline and critical drug development phase

542 views